abstract |
MONOCLONAL ANTIBODIES AGAINST TISSUE FACTOR PATH INHIBITOR, ITS USES, EUKARYOTIC CELL, AS WELL AS PHARMACEUTICAL COMPOSITION. The invention relates to antibodies that specifically bind tissue factor pathway inhibitor (TFPI) and reduce blood clotting time. Such antibodies are of use in treating individuals with a coagulopathy. |